ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,375Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1448

$1.11M Total Retail Price of All Prescriptions

Rank: 23 out of 1448

673 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 17,515 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,276 1,192 1 2
PRAVASTATIN SODIUM 1,062 966 2 20
OMEPRAZOLE 815 751 3 23
SIMVASTATIN 757 670 4 3
METFORMIN HCL 717 630 5 25
HYDROCHLOROTHIAZIDE 716 654 6 18
ALENDRONATE SODIUM 614 589 7 41
LISINOPRIL 582 525 8 5
DIOVAN HCT 444 414 9 29
CARVEDILOL 416 370 10 1
FUROSEMIDE 405 378 11 7
LOSARTAN POTASSIUM 398 385 12 11
DIOVAN 384 354 13 15
LEVOTHYROXINE SODIUM 366 341 14 21
TRAMADOL HCL 333 294 15 56
ZOLPIDEM TARTRATE 326 289 16 34
GLIMEPIRIDE 293 263 17 66
RANITIDINE HCL 280 247 18 109
KLOR-CON 8 267 254 19 70
ATENOLOL 259 214 20 12
BENAZEPRIL HCL 236 205 21 26
AZITHROMYCIN 231 203 22 76
METOPROLOL SUCCINATE 224 219 23 6
IBUPROFEN 219 199 24 85
ALLOPURINOL 219 207 24 43
JANUVIA 219 188 24 64
CLOPIDOGREL 197 177 27 10
LOSARTAN-HYDROCHLOROTHIAZIDE 186 181 28 38
ZETIA 175 152 29 28
NEXIUM 167 146 30 49
ISOSORBIDE MONONITRATE ER 162 152 31 16
CRESTOR 160 148 32 17
SINGULAIR 159 150 33 91
NAPROXEN 155 130 34 112
GLIPIZIDE 145 134 35 75
DOXAZOSIN MESYLATE 143 125 36 65
SERTRALINE HCL 133 114 37 99
ACTOS 133 126 37 92
PLAVIX 131 120 39 14
DIGOXIN 128 127 40 13
ATORVASTATIN CALCIUM 126 111 41 4
POTASSIUM CHLORIDE 111 95 42 19
TAMSULOSIN HCL 109 99 43 46
FLUTICASONE PROPIONATE 109 91 43 130
LANTUS 106 92 45 111
BYSTOLIC 105 105 46 32
WARFARIN SODIUM 104 103 47 8
MONTELUKAST SODIUM 102 94 48 135
CITALOPRAM HBR 102 90 48 129
METOPROLOL TARTRATE 90 87 50 9
CIPROFLOXACIN HCL 88 84 51 137
MECLIZINE HCL 85 72 52 108
PROAIR HFA 84 71 53 104
GLYBURIDE-METFORMIN HCL 84 74 R 53 132
SPIRONOLACTONE 84 84 53 24
TRICOR 83 71 56 94
TRILIPIX 74 74 57 86
BUSPIRONE HCL 70 55 58 349
LEVOFLOXACIN 69 57 59 131
GABAPENTIN 67 53 60 51
EXFORGE 66 66 61 80
GLYBURIDE 64 50 R 62 89
FENOFIBRATE 63 48 63 54
RANEXA 61 60 64 37
VALSARTAN-HYDROCHLOROTHIAZIDE 60 57 65 212
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 66 67
TRAZODONE HCL 57 48 67 128
ACTONEL 55 55 68 117
PANTOPRAZOLE SODIUM 53 49 69 42
CLONIDINE HCL 53 45 69 45
CELEBREX 52 52 71 77
NITROSTAT 52 49 71 31
INSULIN SYRINGE 52 42 71 139
CYMBALTA 50 35 74 123
CILOSTAZOL 50 35 74 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.